Skip to content
value.today

Paradigm Biopharmaceuticals Limited

PAR.AX
$107 Mlast known market cap, Jan 2024 — no current value
Compare
World rank
—
no current market cap
Revenue
—
annual
Net income
—
Employees
—

Paradigm Biopharmaceuticals Limited in brief

Paradigm Biopharmaceuticals Limited is a listed company in the Biotechnology industry, based in Australia. Its last known market value was $107 M (January 2024); there is no current figure. Its shares trade under the symbol PAR.AX (ASX).

Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.

Paradigm Biopharmaceuticals Limited timeline

1 events, 2015
  1. 2015
  2. 🔔
    Initial public offering on Australian Securities Exchange as PAR

Events of Paradigm Biopharmaceuticals Limited from Wikidata. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.

Market cap history

$0 M$119 M$238 M$357 M$476 M20202021202220232024

World rank over time

▼ down 8,865 places since 2020
2020-01-01: #12177#12,17720202021-01-01: #11772#11,77220212022-01-07: #16677#16,67720222022-12-25: #16211#16,21120222023-07-30: #18630#18,63020232024-01-05: #21042#21,0422024

Rank in Australia: #256 (Jan 2020) · #266 (Jan 2021) · #383 (Jan 2022) · #335 (Dec 2022) · #400 (Jul 2023) · #484 (Jan 2024)

Mutual funds holding Paradigm Biopharmaceuticals Limited#

1 funds hold shares worth $0 M. Since their previous reports 0 added shares and 1 sold, selling $0 M net.
Mutual funds holding Paradigm Biopharmaceuticals Limited
FundSharesValueOf the companyOf the fundChange in sharesReport
🇺🇸 Dimensional International Small Cap ETFDimensional Fund Advisors LP54,522$0 M—<0.01%no changeJul 31, 2026

Source: Fund portfolio reports to the SEC (Form N-PORT), CVM, Finansinspektionen and Indian fund houses · as of Jul 31, 2026. The 1 largest positions, each from the fund's newest report; report dates differ between funds. A fund family's funds are listed one by one, so one manager can appear many times.

Peer comparison · Biotechnology

CompanyMarket capP/ENet marginRev. growth
Paradigm Biopharmaceuticals Limited🇦🇺$107 M———
Novo Nordisk A/S🇩🇰$203.2 B13.1×33.1%+10.8%
Vertex Pharmaceuticals Incorporated🇺🇸$134.3 B33.8×30.7%+8.9%
Moderna, Inc.🇺🇸$90.1 B—-110.5%-39.9%
Regeneron Pharmaceuticals, Inc.🇺🇸$84.1 B17.5×28.5%+1.0%
Argenx SE🇳🇱$52.8 B40.9×31.1%+89.9%
CSL Limited🇦🇺$51.6 B—-16.4%—
Samsung Biologics Co., Ltd.🇰🇷$51.5 B40.5×39.2%—
UCB SA🇧🇪$48.6 B26.3×20.1%+31.1%

P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.

Questions, comparisons and similar companies#

Sources and freshness

Market cap:
Jan 5, 2024 (last known)
Profile updated:
Nov 4, 2026

Figures from value.today research, Wikidata.

How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.

Work at Paradigm Biopharmaceuticals Limited? Verify and update this profile — free

Use your work e-mail address (on the company's own domain if possible). Fill in only what is new or missing; a link to where the figures are published (annual report, press release) speeds up the review.

Show Paradigm Biopharmaceuticals Limited's ranking on your website Get the badge
Badge preview

The badge updates itself as the ranking changes.

Something wrong or missing about Paradigm Biopharmaceuticals Limited? Suggest a correction